Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-04 Purchase | 2024-11-06 4:20 pm | BRIGHT MINDS BIOSCIENCES INC. | DRUG | Cormorant Asset Management LP Chen Bihua 10% Owner | 184,331 | $21.7 | $3,999,983 | 1,059,331 (Indirect) | View |
| 2024-10-15 Purchase | 2024-10-17 5:11 pm | BRIGHT MINDS BIOSCIENCES INC. | DRUG | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Chen Bihua 10% Owner | 422,591 | $7.6537 | $3,234,387 | 875,000 (Indirect) | View |
| 2024-09-27 Purchase | 2024-10-01 4:01 pm | BioAge Labs Inc. | BIOA | Cormorant Asset Management LP Cormorant Private Healthcare Fund V LP Chen Bihua Cormorant Private Healthcare Fund IV LP Former 10% Owner | 450,000 | $18 | $8,100,000 | 1,629,529 (Indirect) | View |
| 2024-09-20 Purchase | 2024-09-24 4:04 pm | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 350,000 | $20.01 | $7,003,761 | 2,375,000 (Indirect) | View |
| 2024-05-06 Purchase | 2024-05-08 4:23 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 850,000 | $11.86 | $10,081,721 | 8,325,000 (Indirect) | View |
| 2024-04-18 Purchase | 2024-04-22 4:00 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 581,765 | $18.03 | $10,489,446 | 7,475,000 (Indirect) | View |
| 2024-04-01 Sale | 2024-04-03 5:37 pm | Immuneering Corp | IMRX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 400,000 | $2.9005 | $1,160,181 | 2,895,273 (Indirect) | View |
| 2024-03-14 Sale | 2024-03-18 5:59 pm | Immuneering Corp | IMRX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 909,091 | $3.0239 | $2,749,003 | 3,295,273 (Indirect) | View |
| 2024-03-07 Purchase | 2024-03-11 5:34 pm | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 550,000 | $42.41 | $23,327,560 | 2,025,000 (Indirect) | View |
| 2024-02-02 Purchase | 2024-02-06 4:00 pm | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Chen Bihua 10% Owner | 750,000 | $19 | $14,250,000 | 1,475,000 (Indirect) | View |
| 2024-01-26 Purchase | 2024-01-30 4:23 pm | Corbus Pharmaceuticals Holdings Inc. | CRBP | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Chen Bihua 10% Owner | 282,632 | $32.24 | $9,111,941 | 725,000 (Indirect) | View |
| 2024-01-09 Purchase | 2024-01-11 4:00 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 855,000 | $19.94 | $17,051,100 | 6,893,235 (Indirect) | View |
| 2023-12-08 Purchase | 2023-12-12 4:52 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 588,235 | $17 | $9,999,995 | 6,038,235 (Indirect) | View |
| 2023-12-04 Purchase | 2023-12-06 4:39 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 1,919,057 | $21.82 | $41,874,151 | 5,450,000 (Indirect) | View |
| 2023-10-23 Purchase | 2023-10-25 4:15 pm | Ambrx Biopharma Inc. | AMAM | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 1,307,311 | $6.9911 | $9,139,542 | 11,231,000 (Indirect) | View |
| 2023-10-05 Purchase | 2023-10-10 4:00 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP 10% Owner | 58,839 | $59.9 | $3,524,297 | 8,494,151 (Indirect) | View |
| 2023-10-02 Purchase | 2023-10-04 5:52 pm | MoonLake Immunotherapeutics | MLTX | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Cormorant Private Healthcare Fund III LP Cormorant Private Healthcare Fund IV LP 10% Owner | 293,212 | $57.3 | $16,800,343 | 8,435,312 (Indirect) | View |
| 2023-09-15 Purchase | 2023-09-19 4:49 pm | Ambrx Biopharma Inc. | AMAM | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 2,152,738 | $9.1166 | $19,625,601 | 69,465,823 (Indirect) | View |
| 2023-07-20 Sale | 2023-07-24 4:01 pm | GreenLight Biosciences Holdings PBC | GRNA | Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Chen Bihua (See below) | 9,188,659 | $0 | $0 | 0 (Indirect) | View |
| 2023-04-18 Purchase | 2023-04-20 6:04 pm | Ambrx Biopharma Inc. | AMAM | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 5,215,189 | $11.3 | $58,950,690 | 67,313,085 (Indirect) | View |
| 2023-04-13 Purchase | 2023-04-17 5:46 pm | Ambrx Biopharma Inc. | AMAM | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 2,597,896 | $9.7461 | $25,319,289 | 62,097,896 (Indirect) | View |
| 2023-03-30 Purchase | 2023-04-03 4:30 pm | Biomea Fusion Inc. | BMEA | Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Cormorant Asset Management LP Director 10% Owner | 400,000 | $30 | $12,000,000 | 3,623,650 (Indirect Direct) | View |
| 2023-03-14 Purchase | 2023-03-16 6:04 pm | Ambrx Biopharma Inc. | AMAM | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner | 1,000,000 | $10.21 | $10,211,400 | 53,500,000 (Indirect) | View |
| 2022-12-13 Purchase(A) | 2022-12-21 4:33 pm | Erasca Inc. | ERAS | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Director | 307,692 | $6.5 | $1,999,998 | 11,019,912 (Indirect Direct) | View |
| 2022-12-13 Purchase | 2022-12-20 5:42 pm | Erasca Inc. | ERAS | Chen Bihua Cormorant Asset Management LP Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund II LP Director | 307,692 | $6.5 | $1,999,998 | 11,019,912 (Indirect Direct) | View |
| 2021-10-25 Purchase | 2021-10-27 4:04 pm | Ventyx Biosciences Inc. | VTYX | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP Former 10% Owner | 625,000 | $16 | $10,000,000 | 1,410,303 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion